
Dr Eliot Peyster
About
Dr Eliot Peyster is the Director of Cardiovascular Translational Medicine at the Wesley Research Institute and an Adjunct Professor of Medicine at the University of Pennsylvania and the University of Queensland. He is a cardiologist and transplant physician whose research integrates spatial biology, advanced computational methods, and novel human tissue models to drive precision medicine breakthroughs in cardiovascular disease, heart failure, and organ transplantation.
Dr Peyster has led pioneering studies applying machine learning and computer vision to improve diagnosis and prediction in diseases of both the native and transplanted hearts, earning national research awards, multiple patents, and international recognition. Building on this expertise, his group is now establishing real-world workflows for AI and computer-vision-based clinical decision support. In pursuit of further real-world impact, his group is now developing living human heart tissue platforms for ex-vivo therapeutic trials — enabling direct testing of new drugs and interventions in real human myocardium before they reach patients.
Current research focuses on uncovering human-specific mechanisms and biomarkers in cardiac sarcoidosis, coronary artery disease, transplant rejection, and heart failure, while developing new translational pipelines that accelerate therapies from the lab to the clinic.
Qualifications
Doctor of Medicine (MD) – Drexel University College of Medicine
Internal Medicine Residency – University of Pennsylvania
Cardiovascular Medicine Fellowship – University of Pennsylvania
Masters in Translational Research – University of Pennsylvania
Advanced Heart Failure and Transplant Medicine Fellowship – University of Pennsylvania
Featured Publications
Peyster EG, Chaumont C, Siontis KC, Kapa S, Markman T, Pathak RK, Oraii A, Rodriguez-Queralto O, Anselme F, Margulies KB, Marchlinski FE, Frankel DS. Unipolar Voltage Mapping to Predict Recovery of Left Ventricular Ejection Fraction in Patients with Recent Onset Nonischemic Cardiomyopathy. Circulation 2025 Feb 11;151(6):368-378
ArabYarmohammadi S, Yuan C, Viswanathan VS, Lal P, Feldman MF, Margulies KB, Madabhushi A, Peyster EG. Failing to Make the Grade: Conventional Cardiac Allograft Rejection Grading Criteria are Inadequate for Predicting Rejection Severity. Circ Heart Failure, 17;2. 2024
Peyster EG, Janowczyk A, Swamidoss A, Kethireddy S, Feldman MD, Margulies KB. Computational Analysis of Routine Biopsies Improves Diagnosis and Prediction of Cardiac Allograft Vasculopathy. Circulation. 2022; 145:1563–1577
Peyster EG, ArabYarmohammadi S, Janowczyk A, Azarianpour-Esfahani S, Sekulic M, Cassol C, Blower L, Parwani A, Lal P, Feldman MF, Margulies KB, Madabhushi A. An Automated Computational Image Analysis Pipeline for Histologic Grading of Cardiac Allograft Rejection. Eur Heart J. 2021 Jun 21;42(24):2356-2369.
Peyster EG, Remeniuk B, Feldman MF, Margulies KB. In-situ Immune Profiling of Heart Transplant Biopsies Improves Diagnostic Accuracy & Rejection Risk Stratification. JACC Basic Trans Sci. 2020;5:328–340
Affiliations
2025 – Present – University of Queensland – Institute of Molecular Biosciences – Adjunct Associate Professor
2020- Present – University of Pennsylvania – Penn Cardiovascular Institute – Adjunct Professor of Medicine
Awards
Northwestern Cardiac Young Investigator Forum – Junior Faculty Clinical Science winner – 2020
Northwestern Cardiac Young Investigator Forum – Fellow’s Basic Science award winner – 2019
NIH Clinical and Translational Sciences TL-1 Award – 2018
NIH Post-Baccalaureate Intramural Research Training Fellowship- 2016/2017
Association of Pathology Chairs Honor Society – 2010
Drexel University College of Medicine Teaching Award – 2012
Daniel Mason M.D. HU ’44 Award for Cardiology Clinical Work – 2012
Alpha Omega Alpha – Medical Honor Society – 2011